Quaker Wealth Management’s Revolution Medicines RVMD Stock Holding History

Quaker Wealth Management’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.05K	Buy	10 +2	+25%	+$396	﹤0.01%	427
2026 Q2	$1.5K	Sell	8 -1	-11%	-$146	﹤0.01%	498
2026 Q1	$876	Sell	9 -1	-10%	-$101	﹤0.01%	564
2025 Q4	$797	Buy	10 +2	+25%	+$131	﹤0.01%	587
2025 Q3	$374	Sell	8 -1	-11%	-$39	﹤0.01%	664
2025 Q2	$332	Buy	+9	New	+$346	﹤0.01%	695

Other funds holding RVMD

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Parnassus Investments San Francisco, California $33.8B AUM 31.08% 1-Year Est. Return

Loftus Peak Sydney, Australia $781M AUM

BI Asset Management Fondsmaeglerselskab Kobenhavn, Denmark $13.1B AUM 35.37% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

Asset Management One Tokyo, Japan $40B AUM 30.45% 1-Year Est. Return

STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Quaker Wealth Management's RVMD Position: Q3 2026 in Review

Quaker Wealth Management increased its Revolution Medicines (RVMD) stake by 25% in Q3 2026, buying an estimated $396 and bringing the position to 10 shares worth $2.05K. The position accounts for ﹤0.01% of the portfolio, ranked #427.

Quaker Wealth Management first reported a position in RVMD in Q2 2025 and has held it in 6 quarters since. 224 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

Quaker Wealth Management held 10 shares of Revolution Medicines worth $2.05K as of Q3 2026.
Quaker Wealth Management bought 2 Revolution Medicines shares in Q3 2026, an estimated $396.
Revolution Medicines made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #427 holding.
Quaker Wealth Management first reported a position in Revolution Medicines in Q2 2025 and has held it in 6 quarters since.
224 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.